Description
The National Human Genome Research Institute (NHGRI) has funded the Centers for Common Disease Genomics (CCDG), a collaborative large-scale genome sequencing effort to comprehensively identify rare risk and protective variants contributing to multiple common disease phenotypes and to better understand the general principles of genomic architecture underlying common, complex inherited diseases.
This study of early onset cardiovascular disease and metabolic risk contains data derived from the whole genome sequence data of individuals participating in Penn Medicine's BioBank.
Stats
3Cohorts
2,256Samples
2,256Participants
44.93 TBSize
Summary
Consent CodesConsortia Access Only, TBD,
Diseasesatrial fibrillation, coronary artery disease
AccessConsortium Access Only, Controlled Access
Study DesignCase Set, TBD, Case-Control
Data TypesWhole Genome, TBD
Terra Workspaces
This study has been divided into the following workspaces by consent codes and optionally the originating laboratory.
| Terra Workspace Name | Consent Code | Disease | Access | Study Design | Data Type | Samples | Participants | Size (TB) |
|---|---|---|---|---|---|---|---|---|
| AnVIL_CCDG_Broad_CVD_AFib_Penn_WGS | Consortia Access Only | atrial fibrillation | Consortium Access Only | Case Set | Whole Genome | 418 | 418 | 8.56 |
| AnVIL_CCDG_TOPMed_WashU_CVD_Afib_Penn_WGS | TBD | atrial fibrillation | Controlled Access | TBD | TBD | 482 | 482 | 9.36 |
| AnVIL_CCDG_WashU_CVD_EOCAD_Penn_WGS | coronary artery disease | Controlled Access | Case-Control | Whole Genome | 1,356 | 1,356 | 27.01 |
